Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Benzydamine vs Super Saturated Calcium Phosphate for Oral Mucositis in Head and Neck Cancer Radiotherapy
NCT07748442Completed
- Sponsor
- Postgraduate Medical Institute
- Start
- Apr 2022
- Primary completion
- Mar 2023
- Countries
- 1
01
Overview
Open-label trial of benzydamine and supersaturated calcium phosphate rinse in oral mucositis (OM) (2 arms), sponsored by Postgraduate Medical Institute. Primary endpoints: Salivary Macrophage Migratory Inhibitory Factor Levels at 9 weeks and Grade of Oral Mucositis at 6 weeks. Started Apr 2022; status: completed.
02
Drugs
benzydaminesupersaturated calcium phosphate rinse
03
Conditions
oral mucositis (OM)
Beyond the preview
Go deeper on NCT07748442.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07748442.